Characterization of the T-cell response to Coxsackievirus B4: Evidence that effector memory cells predominate in patients with type 1 diabetes

Diabetes

Volumn 51, Issue 6, 2002, Pages 1745-1753

  Varela Calvino, Ruben ^a   Ellis, Richard ^a   Sgarbi, Gianluca ^a   Dayan, Colin M ^b   Peakman, Mark ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VIRUS ENVELOPE PROTEIN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B4; CYTOKINE PRODUCTION; EFFECTOR CELL; ENTEROVIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS ENVELOPE;

EID: 0036263328     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.6.1745     Document Type: Article

References (46)

1. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM: Childhood Diabetes in Finland (DiMe) Study Group
2. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM: A population-based case-control study
3. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections: Childhood Diabetes in Finland (DiMe) Study Group
4. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: The Finnish Diabetes Prediction and Prevention Study
5. Heterogeneity of type 1 diabetes: Analysis of monozygotic twins in Great Britain and the United States
6. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis
7. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type 1) diabetes mellitus
8. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia
9. Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus: Pittsburgh Diabetes Research Group
10. Neonatal type I diabetes associated with maternal echovirus 6 infection: A case report
11. Acute onset of type I diabetes mellitus after severe echovirus 9 infection: Putative pathogenic pathways
12. Simultaneous onset of type 1 diabetes mellitus in identical infant twins with enterovirus infection
13. Onset of type 1 diabetes mellitus in infancy after enterovirus infections
14. Coxsackie B virus infection and onset of childhood diabetes
15. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: A prospective study: Childhood Diabetes in Finland (DiMe) Study Group
16. Enterovirus variants in the serum of children at the onset of type 1 diabetes mellitus
17. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type 1 diabetes mellitus
18. Molecular mimicry and autoimmune disease
19. Molecular mimicry and autoimmunity
20. Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry
21. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology
22. T-cell activation by coxsackievirus b4 antigens in type 1 diabetes mellitus: Evidence for selective TCR Vbeta usage without superantigenic activity
23. Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart
24. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes
25. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects
26. Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with type I diabetes mellitus
27. Responses of coxsackievirus B4-specific T-cell lines to 2C protein-characterization of epitopes with special reference to the GAD 65 homology region
28. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
29. T-Cell reactivity to the P 2C nonstructural protein of a diabetogenic strain of coxsackievirus B4
30. Complete nucleotide sequence of a strain of coxsackie B 4 virus of human origin that induces diabetes in mice and its comparison with nondiabetogenic coxsackie B4 JBV strain
31. T-cell responses to enterovirus antigens in children with type 1 diabetes
32. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
33. Exploring pathways for memory T cell generation
34. Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells
35. Classification of enteroviruses based on molecular and biological properties
36. Orthomyxoviruses
37. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor
38. Identification of T-helper epitopes in the VP1 capsid protein of poliovirus
39. Antigenic sequences of poliovirus recognized by T cells: Serotype-specific epitopes on VP1 and VP3 and crossreactive epitopes on VP4 defined by using CD4+ T-cell clones
40. Analysis of the human T-cell response to picornaviruses: Identification of T-cell epitopes close to B-cell epitopes in poliovirus
41. Mapping of antigenic sites of coxsackievirus B3 by synthetic peptides
42. Antigenic sites of coxsackievirus A9
43. Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4: Childhood Diabetes in Finland Study Group
44. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients
45. Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM
46. Structural basis of molecular mimicry